Project Grant R01GM155404

Award Date 8/15/24
Completion Date 6/30/28
Dollars Obligated $1.3M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This $1,675,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research by Yale University to investigate the post-transcriptional control of gene expression by the mTORC1 signaling pathway. The research aims to answer key questions about the mechanisms underlying cap-dependent and cap-independent translation of mRNAs, how regulation of cap-dependent translation affects mRNA stability,...
This $375,420 Project Grant was awarded on June 1, 2025 by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research conducted by the University of Texas Medical Branch at Galveston (UTMB) to investigate the mechanisms by which canonical and non-canonical translation factors control protein synthesis quality control in bacteria. The proposed studies aim to elucidate how factors like Release...
This $658,165 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to investigate the effects of ions on mRNA elements, ribosomes, and antibiotic-RNA interactions. The research aims to improve the fundamental understanding of ribosome function and mRNA regulation, with a focus on the bacterial ribosome and antibiotic resistance. Key areas of study include how initial codon...
The National Institute of General Medical Sciences (NIGMS) awarded a $445,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Children's Hospital of Philadelphia (CHOP) to develop long-read RNA sequencing technologies and apply them to advancing genomic medicine. The central objective is to harness long-read transcriptomics to elucidate transcriptome complexity and identify therapeutic targets for rare and complex diseases. The 5-year project aims to: 1) develop...
This $390,000 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) will support the development of innovative proteomic technologies to study transcription factor-coregulator interactions. The award aims to pioneer DNA barcode-based methods that can enhance the specificity and reproducibility of existing techniques like mass spectrometry-based RIME for characterizing epigenetic...
The National Institute of General Medical Sciences (NIGMS) awarded a $300,518 Project Grant under CFDA Program 93.859 (Biomedical Research and Research Training) to E&E Bioclub LLC in Indianapolis, IN. The project aims to develop an all-in-one platform for intracellular overproduction of long, single-strand mRNA. This is intended to address challenges with current mRNA manufacturing methods, such as the cost and scalability constraints of in vitro transcription and the difficulty in...
This National Science Foundation (NSF) Biological Sciences program grant to Yale University, totaling $940,000 over 3 years beginning March 1, 2024, aims to systematically identify features of human and viral messenger RNAs (mRNAs) that regulate protein production. The project will employ a massively parallel reporter assay to quantify the impact of RNA modifications, structured RNA elements, and cell-specific factors on mRNA translation. Insights gained will provide a comprehensive...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under CFDA Program 93.859 Biomedical Research and Research Training, provides $372,880 in funding to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to conduct research on the regulation of protein synthesis during cellular stress. The key objectives of the research project are to: 1) understand how the formation of the essential eIF2 translation initiation factor...
This federal Project Grant award, funded by the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research), aims to develop new genomic and computational approaches to understand the functional impact of genetic variation in the 5' and 3' untranslated regions (UTRs) of mRNA and its effect on protein output and gene function. The primary goals are to: 1) Identify and characterize variants in human 5' and 3' UTRs, and quantify the regulatory activity of each variant on mRNA...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $680,790 to the University of Florida to conduct research focused on linking gene function through comparative genomic and experimental approaches. The key research projects aim to: 1) identify missing tRNA modification genes, including transporters for the queuosine (Q) micronutrient, and 2) study the role of orphan pyridoxal...

The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), awarded a $1,301,595 Project Grant to Yale University to conduct research on the translation of overprinted non-canonical open reading frames (iorfs) from alternative transcript variants. The project aims to: 1) apply long-read sequencing to identify and validate the existence of iorf-encoding alternative transcripts, 2) provide molecular and cellular evidence that iorfs are functional and determine their cellular roles, and 3) characterize the molecular mechanism and regulation of an anti-apoptotic iorf that overlaps a pro-apoptotic protein. This research is expected to demonstrate the prevalence and functionality of overlapping human genes and provide new insights into the roles of alternative transcript variants in the human transcriptome and proteome.

Generated 7/8/25, 12:40 PM